These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29211454)

  • 1. Latent Warheads for Targeted Cancer Therapy: Design and Synthesis of pro-Pyrrolobenzodiazepines and Conjugates.
    Vlahov IR; Qi L; Kleindl PJ; Santhapuram HK; Felten A; Parham GL; Wang K; You F; Vaughn JF; Hahn SJ; Klein HF; Vetzel M; Reddy JA; Nelson M; Nicoson J; Leamon CP
    Bioconjug Chem; 2017 Dec; 28(12):2921-2931. PubMed ID: 29211454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of a folate-receptor targeted diazepine-ring-opened pyrrolobenzodiazepine prodrug conjugate.
    Vlahov IR; Qi L; Santhapuram HKR; Felten A; Parham GL; Zou N; Wang K; You F; Vaughn JF; Hahn SJ; Klein HF; Kleindl PJ; Reddy J; Reno D; Nicoson J; Leamon CP
    Bioorg Med Chem Lett; 2020 Apr; 30(7):126987. PubMed ID: 32029324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of pyrrolobenzodiazepines as antitumour agents.
    Hartley JA
    Expert Opin Investig Drugs; 2011 Jun; 20(6):733-44. PubMed ID: 21457108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in novel pyrrolo[2,1-c][1,4]benzodiazepine conjugates: synthesis and biological evaluation.
    Kumar R; Lown JW
    Mini Rev Med Chem; 2003 Jun; 3(4):323-39. PubMed ID: 12678826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in the design, synthesis and structure-activity relationship studies of pyrrolo[2,1-c][1,4]benzodiazepines as DNA-interactive antitumour antibiotics.
    Kamal A; Rao MV; Laxman N; Ramesh G; Reddy GS
    Curr Med Chem Anticancer Agents; 2002 Mar; 2(2):215-54. PubMed ID: 12678745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrocyclic pyrrolobenzodiazepine dimers as antibody-drug conjugate payloads.
    Donnell AF; Zhang Y; Stang EM; Wei DD; Tebben AJ; Perez HL; Schroeder GM; Pan C; Rao C; Borzilleri RM; Vite GD; Gangwar S
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5267-5271. PubMed ID: 29102228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs).
    Mantaj J; Jackson PJ; Rahman KM; Thurston DE
    Angew Chem Int Ed Engl; 2017 Jan; 56(2):462-488. PubMed ID: 27862776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrrolo[2,1-c][1,4]benzodiazepine as a scaffold for the design and synthesis of anti-tumour drugs.
    Cipolla L; Araújo AC; Airoldi C; Bini D
    Anticancer Agents Med Chem; 2009 Jan; 9(1):1-31. PubMed ID: 19149479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence-selective binding of C8-conjugated pyrrolobenzodiazepines (PBDs) to DNA.
    Basher MA; Rahman KM; Jackson PJM; Thurston DE; Fox KR
    Biophys Chem; 2017 Nov; 230():53-61. PubMed ID: 28941814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of pyrrolobenzodiazepine dimer antibody-drug conjugates with dual β-glucuronide and dipeptide triggers.
    Gregson SJ; Barrett AM; Patel NV; Kang GD; Schiavone D; Sult E; Barry CS; Vijayakrishnan B; Adams LR; Masterson LA; D'Hooge F; Snaith M; Harper J; Hartley JA; Howard PW
    Eur J Med Chem; 2019 Oct; 179():591-607. PubMed ID: 31279293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalent Bonding of Pyrrolobenzodiazepines (PBDs) to Terminal Guanine Residues within Duplex and Hairpin DNA Fragments.
    Mantaj J; Jackson PJ; Karu K; Rahman KM; Thurston DE
    PLoS One; 2016; 11(4):e0152303. PubMed ID: 27055050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrrolobenzodiazepine Dimer Antibody-Drug Conjugates: Synthesis and Evaluation of Noncleavable Drug-Linkers.
    Gregson SJ; Masterson LA; Wei B; Pillow TH; Spencer SD; Kang GD; Yu SF; Raab H; Lau J; Li G; Lewis Phillips GD; Gunzner-Toste J; Safina BS; Ohri R; Darwish M; Kozak KR; Dela Cruz-Chuh J; Polson A; Flygare JA; Howard PW
    J Med Chem; 2017 Dec; 60(23):9490-9507. PubMed ID: 29112410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of pyrrolobenzodiazepine-containing hypoxia-activated prodrugs.
    Dragovich PS; Broccatelli F; Chen J; Fan P; Le H; Mao W; Pillow TH; Polson AG; Wai J; Xu Z; Yao H; Zhang D
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5300-5304. PubMed ID: 29079474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of pyrrolo[2,1-c][1,4]benzodiazepine β-glucoside prodrugs for selective therapy of cancer.
    Adiyala PR; Tekumalla V; Sayeed IB; Nayak VL; Nagarajan A; Shareef MA; Nagaraju B; Kamal A
    Bioorg Chem; 2018 Feb; 76():288-293. PubMed ID: 29223805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of an N10-Psec substituted pyrrolo[2,1-c][1,4]benzodiazepine prodrug.
    Berry JM; Howard PW; Kelland LR; Thurston DE
    Bioorg Med Chem Lett; 2002 May; 12(10):1413-6. PubMed ID: 11992788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of Pyrrolobenzodiazepine (PBD)-Dimers Containing Disulfide-Based Prodrugs as Payloads for Antibody-Drug Conjugates.
    Pei Z; Chen C; Chen J; Cruz-Chuh JD; Delarosa R; Deng Y; Fourie-O'Donohue A; Figueroa I; Guo J; Jin W; Khojasteh SC; Kozak KR; Latifi B; Lee J; Li G; Lin E; Liu L; Lu J; Martin S; Ng C; Nguyen T; Ohri R; Lewis Phillips G; Pillow TH; Rowntree RK; Stagg NJ; Stokoe D; Ulufatu S; Verma VA; Wai J; Wang J; Xu K; Xu Z; Yao H; Yu SF; Zhang D; Dragovich PS
    Mol Pharm; 2018 Sep; 15(9):3979-3996. PubMed ID: 30040421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates: Design, synthesis and biological evaluation as potential anticancer agents.
    Kamal A; Vijaya Bharathi E; Janaki Ramaiah M; Dastagiri D; Surendranadha Reddy J; Viswanath A; Sultana F; Pushpavalli SN; Pal-Bhadra M; Srivastava HK; Narahari Sastry G; Juvekar A; Sen S; Zingde S
    Bioorg Med Chem; 2010 Jan; 18(2):526-42. PubMed ID: 20031423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy.
    Masterson LA; Spanswick VJ; Hartley JA; Begent RH; Howard PW; Thurston DE
    Bioorg Med Chem Lett; 2006 Jan; 16(2):252-6. PubMed ID: 16290933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of aryl-substituted naphthalene-linked pyrrolobenzodiazepine conjugates as potential anticancer agents with apoptosis-inducing ability.
    Kamal A; Reddy MK; Ramaiah MJ; Srikanth YV; Rajender ; Reddy VS; Kumar GB; Pushpavalli SN; Bag I; Juvekar A; Sen S; Zingde SM; Pal-Bhadra M
    ChemMedChem; 2011 Sep; 6(9):1665-79. PubMed ID: 21732540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR.
    Mao S; Chaerkady R; Yu W; D'Angelo G; Garcia A; Chen H; Barrett AM; Phipps S; Fleming R; Hess S; Koopmann JO; Dimasi N; Wilson S; Pugh K; Cook K; Masterson LA; Gao C; Wu H; Herbst R; Howard PW; Tice DA; Cobbold M; Harper J
    Mol Cancer Ther; 2021 Mar; 20(3):541-552. PubMed ID: 33653945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.